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1. Introduction 
Healthcare-associated urinary infection is one of the most frequent infections and it is 
responsible for more than 40% of nosocomial or healthcare-associated infections (HAIs) and 
nursing homes for the elderly. The complexity and diversification of health services 
currently offered has motivated an enlargement in literature about infectious complications 
that may happen in each one of these scenarios; and according to the recommendations 
from literature since 2007 (1), in this chapter, urinary tract infection will be approached as a 
result of the care provided at hospitals or nosocomial care (NUTI). 
Due to the fact that most of NUTIs are associated to urinary tract instrumentation, i.e. 
secondary to either indwelling or intermittent vesical catheterization, cystoscopies or any 
invasive urologic procedures, or to nephrostomy tube placement, this chapter will 
emphasize in the most recurrent complication derived from the use of these medical 
devices: urinary catheter-associated bacteriuria (UCAB). 
2. Epidemiology 
The risk to acquire a NUTI depends on: location of Urinary Catheter (UC), catheterization’s 
period of time, catheter care measures and host’s susceptibility. 13.2 % of inpatients, 4.9% in 
nursing homes for the elderly and 3.9% of home care patients have urinary catheters (14). 
After just one catheterization of the urinary tract, infection rates vary from 1% to 5% to 100% 
in patients who have indwelling urinary catheter with open drainage system. Likewise, and 
regardless of the use of closed drainage system, more than 20% of patients with urinary 
catheters might become infected when mishandling of closed drainage system (3, 4).  
Among risk factors that increase acquiring a catheter-associated urinary tract infection 
(CAUTI) are: advanced age, debilitating disease and postpartum. 
In the National Nosocomial Infections Surveillance in United States, between 1992 and 1997, 
data from 112 medical intensive care units was includes with 181.993 patients and 715.930 
patient-days of follow up. They found 14.177 HAIs, where NUTI was the most frequent 
diagnosis, with 31% of the cases, followed by nosocomial pneumonia and primary 
bloodstream infection (5). 
Information about the epidemiology of nosocomial infections is provided in developing 
countries by the International Nosocomial Infection Control Consortium (INICC). This 
multicenter, international surveillance system proceeded data in 2008 about 98 intensive 
care units around the world. Those units belonged public and private hospitals in 18 
countries in Latin-America, Africa, Asia and Europe. Between 2002 and 2007 a total of 1212 
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NUTI were reported in 202.311 patient-days, with a median rate of 6.49 per 1.000 catheter-
days. Those ICU that had medical and neurosurgical patients had the highest rates, with 
9.63 and 8.29 infection per 1.000 catheter-days, respectively (6).  Previous studies have 
shown that different kinds of patients had different rates of infections because of different 
risk factors that need to be addressed with different control strategies. 
Urinary Catheter-associated NUTIs are caused by a variety of pathogens: E. coli, Klebsiella, 
Proteus, Enterococcus, Pseudomonas, Enterobacter, Serratia and Candida. Many of these 
microorganisms constitute intestinal flora, but they can also be acquired through cross 
contamination from other patients or hospital personnel, or through exposure to 
contaminated solutions or non-sterile equipment. NUTIs produced by Serratia marcescens y 
Pseudomonas cepacia have great epidemiologic meaning since its isolation from catheterized 
patients clearly suggest that they are obtained from exogenous flora, as normally these 
organisms are not part of the intestinal flora. 
Secondary becteremia for NUTI can be present even in a 4% of the patients and it occupies 
the second place among bacteremias of secondary cause; it has even been related to 
mortality rates ranging from 13 to 30%, nonetheless, in a study performed in a ICU to 
determine the impact on UC use in death outcomes, it showed that once all confounding 
variables were controlled, mortality was not higher in patients with UC --mortality in ICU 
patients OR 0,846 (IC 95% 0,695-1,086) versus mortality in hospitals OR 0,949 (IC 95% 0,763-
1,181) -- (7).     
3. Urinary catheters (UC) 
Every year, millions of UCs are used in the different hospital services: Intensive Care Units 
(ICU), rehabilitation, neurology, neurosurgery and internal medicine, also in nursing homes 
for the elderly. Approximately, 25% patients in hospitals use UCs, considering the following 
criteria for its use: 
1. Surgery 
2. Urine output measure 
3. Urine voiding when urine retention; generally caused by processes of urinary tract 
obstruction. 
4. Urinary incontinence (8). 
The majority of urinary tract complications are second to bacteriuria production. Trauma 
and urethritis are other less frequent complications. 
A urinary catheter is a device which has been used since 1927, when Frederick E.B. Foley 
introduced it to control post-surgical bleeding in prostatectomy (9). From 1927 until 1950, 
UCs were used as open drainage system, i.e., urine made contact with air when drained, this 
led to 100% of the patients with open drainage system to develop bacteriuria at the fourth 
day of use (10). From 1950 to 1960, another system was implemented. This system used a 
drainage tube connected to a bag which collected urine, thus leading to the origin of closed 
drainage system. In this case, 100% of the patients developed bacteriuria at the thirtieth day 
of use. (9, 11) 
Urinary catheters are classified as per: 
1. Place of insertion. 
2. Period of catheterization. 
3. Material 
Regarding the first, they can be urethral, suprapubic or nephrostomy catheters. As for the 
period of catheterization, there are two kinds, one for long-term catheterization, usually 
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with indwelling Foley catheters, and for short-term catheterization, nelaton intermittent 
catheters are commonly used. And finally, catheters can be made in latex, silicone or Teflon, 
they can be latex or silicone-covered and some are coated with an antiseptic or antibiotic. 
They also have different diameters. 
The majority of nosocomial CAUTIs are produced by bacteria which come from patient’s 
own colon, which is known as endemic infection, whereas epidemic or secondary infection 
can be explained by different causes: incorrect aseptic techniques for equipment such as 
cystoscopes, contaminated irrigation solutions or contaminated disinfectants used for 
cleaning before catheter insertion, and the most recurrent: cross –transmission through 
hospital personnel hands. 
4. Pathogenesis 
NUTI production is often multifactorial, the main mechanisms to describe the process are: 
4.1 Defense process and urinary infection 
An average urinary tract has defense mechanisms to prevent or minimize interaction 
between epithelial cells and bacteria. Though a large amount of infectious agents that cause 
UTI previously colonize the periurethral area, the urethra represents the first obstacle for 
these agents to reach the bladder.  Had the microorganism gone through the urethra and 
entered the bladder, micturition will purify 99.9% of these bacteria with the help of 
uromodulin and oligosaccharide -which are present in urine-, by a neutralizing action. 
However, a biofilm may remain adhered to the vesical mucosa, in which case, 
glycosaminoglycan inhibits bacterial adherence to epithelial cells. Still, in the case that these 
cells become infected; an acute inflammatory response is produced as a result of cytokine 
liberation of the infected epithelial cells. The last protecting instance of epithelial cells is an 
exfoliation process through which microorganisms are removed from the host. Antibody 
production and host cellular response contribute to a slower reaction, thus helping in the 
last states of acute infection.  
4.2 Biofilms and urinary catheters 
UC use can interfere with some of these natural defense mechanisms. Catheters increase 
urethral colonization by uropathogens, especially in women. Both, inner and outer catheter 
surfaces are niches where bacteria adhere to creating a biofilm which covers and protects 
bacteria from urinary flow and polymorphonuclear action. 
A biofilm is a microorganism community that permanently adheres to biological or inert 
surfaces and it is embedded in a matrix of extracellular polymeric substances modifying 
growing and genetic transcription phenotypes. Bacteria constitute biofilms in especially 
high-stress environments, e.g. fast and turbulent flow milieus, which in return increases 
adhesion of floating cells on surfaces. Once a biofilm is formed and the exopolysaccharide 
matrix has been secreted by cells, the resultant structure is highly viscoelastic and resistant 
to mechanical breaking. Hence, the nature in structure and physiological attributes of 
biofilm’s constituent organisms provide an inherent resistance to antimicrobial agents. (12) 
4.3 Handling and care precautions of urinary catheters 
Another factor encouraging CAUTIs in health care institutions is a failure in the draining 
system, therefore, large amounts of bacteria remain in the bladder and catheter presence 
interrupts interaction between glycosaminoglycan and epithelial cells. (11) 
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4.4 Hematogenous or lymphatic dissemination 
It is important to remember that certain microorganism reach the kidney through 
bloodstream dissemination from a distant organ. The most common microorganisms in this 
particular scenario are: S. aureus, Candida,  Salmonella and some species of Pseudomonas, for 
this reason, isolation of any of these in urine always suggests two possible sources: urinary 
tract or a source different from the kidney compromising it through hematogenous 
dissemination. 
To summarize, CAUTIs at health care institutions can be present in four ways (13): 
1. Early extraluminal: By direct inoculation of microorganisms in the bladder at the 
moment of UC insertion. 
2. Late extraluminal: By microorganisms ascending from perineum to urethra and to 
catheter’s outer surface. 
3. Intraluminal: Due to closed-drainage system failure or when collected bag is 
contaminated.  
4. In rare opportunities by hematogenous dissemination as a consequence of a systemic 
disease with kidney as target organ. 
The final consequence of the interaction between host’s defense mechanism and colonizing 
microorganisms in patients with UC is the presence of bacteria in urine or bacteriuria. 
The majority of infectious agents causing catheter-associated bacteriuria originate in 
patient’s own intestinal flora, which at the same time can be regular inhabitants of the colon, 
or exogenous, as in healthcare-associated infections (HAIs). As in UTI’s pathogenesis, 
enterobactericeae can colonize periurethral areas of non-catheterized patients, especially 
women. Exogenous microorganisms can colonize UC through means of care personnel 
manipulation or less frequent circumstances, as in polluted products. 
5. Risk factor for bacteriuria development 
Asymptomatic bacteriuria is common but its prevalence among general public varies 
significantly with age, gender, and the presence of genitourinary tract alterations. 
Bacteriuria risk for catheterized patients is approximately 25% and its significance in 
relation to provide or not antimicrobial treatment in the asymptomatic patient is debatable 
considering that 80% of short-term catheterized patients receive antimicrobial treatment for 
a different purpose than that of a UTI. (14) 
In a multivariate analysis and observations of 1474 catheterized patients, Platt et al., found 
nine independent risk factors for catheter-associated bacteriuria development. (15) 
1. Period of catheterization 
2. Lack of urinometer usage 
3. Collector bag colonized by microorganisms 
4. Diabetes mellitus 
5. Lack of antibiotic usage 
6. Mishandling in UC procedures 
7. Female gender 
8. Abnormal creatinine 
9. Incorrect catheter care 
5.1 Period of catheterization 
According to UC usage standards, catheterization periods vary: 
1. Surgery: 1-7 days 
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2. Cardiac output measure: 7-30 days 
3. Urinary retention:  1-30 days 
4. Urinary incontinence:  >30 days 
Period of catheterization is the main risk factor for associated bacteriuria development. Once 
UC is inserted, bacteriuria increases at the rate of 3 to 10% per day of UC permanence 
(catheter day) and, it is estimated that by the thirtieth catheter day, 100% of catheterized 
patients will present bacteriuria. For this reason, it is important to divide the period of 
catheterization in: (i) Short-term, for less than 30 days; and (ii) Long-term, for more than 30 
days. In addition, bacteriuria may be asymptomatic or some symptoms may be identified 
having a real UTI. 
5.2 Short-term catheterization 
Between 15 to 25% of inpatients might have a UC for an average period of 2-4 days and 
approximately 10 to 13% of them will develop bacteriuria in comparison to 1% of non- 
catheterized inpatients that develop bacteriuria.  The most common infectious agent found 
in these patients is E. coli, besides Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus 
mirabilis, Enterobacter sp., Staphylococcus epidermidis, Staphylococcus aureus and Candida 
species. In general, only one microorganism is isolated in the urine culture but 15% can be 
polymicrobial.  Colony count can show a meaningful bacteriuria of equal or more than 105  
bacteria. In general, this bacteriuria, aside from the colony count, is accompanied with 
pyuria. Most short-term UC associated bacteriuria are asymptomatic, nonetheless, lower 
urinary symptoms and fever may be present even in 30% of these patients and less than 5% 
will develop bacteremia. The impact of short-term UC associated bacteriuria on mortality is 
not clear and results from studies have shown to be contradictory. 
5.3 Long-term catheterization 
Long-term catheterization is needed for urinary incontinence in women, lower urinary tract 
obstruction in men as a consequence of prostatic hyperplasia and prostate carcinoma, and to 
urinary obstruction in postrenal failure in women secondary to cervical carcinoma, aside 
from neurogenic bladder related  to spinal cord trauma both in men and women. 
Bacteriuria incidence tends to be similar to that observed in hospitals (3 to 10% per day), 
hence, most patients will have bacteriuria at the end of 30 catheter days. Bacteriuria 
prevalence is a consequence of: 
1. Bacteriuria incidence which is similar to that observed in short-term catheterization, by 
gram-negative and gram-positive bacteria, with an average permanence of a different 
infectious agent every two weeks. 
2. Some bacteria residing for weeks and months in the urinary tract, like E. coli and 
Providencia stuartii. 
Colony count is generally meaningful with 105 colonies or more and more than two 
infectious agents are present in more than 95% of long-term catheterization patients. 
The most common infectious agents identified in these patients are E. coli, P. aeruginosa, P. 
mirabilis, Providencia stuartii y Morganella morganii, the latter two in less frequency. Most 
frequent complications are symptomatic bacteriuria, obstruction, urinary stones, 
periurethral infection, chronic kidney disease, renal failure and cancer when catheter is used 
over several years. 
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5.4 Therapy of asymtomatic bacteriuria 
There is no need for rutinary microbiological studies in catheterized patients presenting 
asymptomatic bacteriuria or funguria, or those who have had treatment for that condition. 
Recommendation A-1 from CDC’s (Control Diseases Centers) guidelines for bacteriuria 
prevention (16).  
Antimicrobial treatment can be considered for women who have persistent asymptomatic 
bacteriuria after catheter removal. Recommendation B-1 (17). 
6. Nosocomial urinary tract infection (NUTI) diagnosis 
Besides presenting symptoms or not, a urine test and a urine culture are necessary to 
confirm either bacteriuria or NUTI. In table 3, CDC and NHSN diagnosis criteria for UTIs 
are shown (26).   
7. Bacteriuria complications treatment 
Several clinical manifestations can be present in patients with asymptomatic bacteriuria 
associated with UC usage. 
 Cystitis is manifested through changes in the macroscopic characteristics of urine and it 
is combined with suprapubic pain, polakiuria, dysuria, urinary urgency, and vesical 
tenesmus, these latter symptoms are present when patients do not have sequelae of 
spinal shock. In the case a patient is catheterized due to spinal shock sequelae, the most 
recurrent symptom is associated with the change of macroscopic characteristics of urine 
(odor, color, and transparency). Urine culture and bacteria’s in vitro susceptibility to 
certain antibiotics should be considered for the choice of antibiotherapy, which can 
range from 7 to 10 days. 
 If the patient presents with  fever, it is strongly recommended to exclude any other 
plausible cause for this symptom; if fever seems to be secondary to pyelonephritis 
caused by UC, then a 14-21 day treatment is implemented depending on the severity of 
the infectious process and on the susceptibility of the infectious agent. 
 Candiduria is present in long-term catheterization patients that have had antibiotics 
previously. Candida presence in urine should be taken as possible hematogenous 
dissemination to kidney or other different organs. When candiduria is a result of 
candidemia or a disseminated candidiasis, it is recommended to exclude a systemic 
infection to determine the period of antimycotic treatment (18). Most of the times, 
candiduria is asymptomatic, but it can include complications such as a bladder or renal 
pelvis fungal bezoar, perinephric abscess and disseminated candidiasis. Treatment for 
asymptomatic candidiasis associated to UC is not clear, however, 40% of candiduria 
ends after UC removal and 20% does when UC is changed; this is a B-III 
recommendation (18). For asymptomatic patients who persist with candiduria and 
require catheter, several therapeutic strategies have been proposed. Bladder irrigation 
with 50 to 200 µg/mL of amphotericine B can clear funguria temporarily and it is not a 
frequent recommendation (recommendation C-III) (18); systemic use of fluconazole 200 
mg/d for 14 days has demonstrated microbiological cure. Antimycotic treatment in 
patients with asymptomatic candiduria is not totally defined, but treatment is 
recommended when undergoing genitourinary surgical procedures. Even with 
apparent microbiological cure by UC removal or with systemic treatment, relapse is 
common, even more when there is still UC use. 
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Urinary tract infection Clinical criteria Laboratory criteria 
Symptomatic NUTI  
At least one of the 
following:  
 
1. At least one of the 
following signs or 
symptoms, without any 
other cause; fever >38ºC, 
urinary urgency, frequency, 
dysuria or suprapubic pain 
and criteria 1 from 
laboratory 
2. At least one of the 
following signs or 
symptoms, without any 
other cause; fever >38ºC, 
urinary urgency, frequency, 
dysuria or suprapubic pain, 
and from laboratory criteria 
2, one of the given criteria. 
3. For children under 1, at 
least one of the following 
signs or symptoms, without 
any other cause; fever 
>38ºC or rectal 
hypothermia <37ºC, apnea, 
bradycardia, dysuria, 
lethargy or vomit, and the 
same 1 and 2 laboratory 
criteria respectively. 
1. Urine culture with less than 
two microorganisms and 
colony count of ≥105 
2. Positive leukocyte esterase; 
pyuria >10 leukocytes per 
hogh magnification field; >3 
erythrocytes per hight 
magnification field; positive 
urine Gram in a non-
cytospinned sample; two 
urine cultures with the 
same microorganism and a 
colony count of ≥102 in a 
patient with previous 
effective antibiotherapy and 
a count of ≤105; medical 
diagnosis or proper medical 
treatment for UTI. 
Asymptomatic 
bacteriuria 
At least one of the 
following: 
 
1. Patient with previous case 
of catheterization within the 
last 7 days and who has not 
fever, urinary urgency, 
dysuria or suprapubic pain, 
and laboratory criteria 1.  
2. Patient who has not had UC 
in the previous 7 days to 
the first urine cultura, and 
that has not presented 
fever, urinary urgency, 
frequency, dysuria or 
suprapubic pain, and 
laboratory criteria 3. 
 
3. Two positive urine cultures 
of ≥105 with less than 2 
microorganisms and 
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Urinary tract infection Clinical criteria Laboratory criteria 
 
Other UTIs (kidney, 
urether, bladder, 
urethra, or 
retroperitoneum)   
At least one of the 
following: 
 
1. Abscess or evidence of 
infection at direct, 
intraoperative or 
histological examination. 
2. At least two of the 
following signs or 
symptoms, without any 
other cause; fever >38ºC, 
focused pain or pain in the 
implicated place, and at 
least one of the following; 
purulent drainage, or any of 
the laboratory criteria 2-5. 
3. For children under 1, at 
least one of the following 
signs or symptoms, without 
any other cause; fever 
>38ºC or rectal 
hypothermia <37ºC, apnea, 
bradycardia, dysuria, 
lethargy or vomit, and at 
least one of the following; 
purulent drainage, or any of 
the laboratory criteria 5-8.  
 
 
4. Positive culture from any 
fluid different from urine.  
5. Positive blood culture from 
suspected infection site. 
6. Compatible image with 
infection (CT scan, NMR, 
Scintigraphy) 
7. Medical diagnosis of 
infection 
8. Adequate medical 
treatment for infection. 
 
Comments: 
The culture taken from the tip of a UC is not laboratory criteria for NUTI diagnosis. 
Urine samples should be obtained using the proper technique, i.e. clean technique or catheterization. 
With children, samples must be taken from catheterization or suprapubic puncture; urine collected 
from perineal bag is not accepted. 
Circumcision-associated infections should be informed as such. 
 
Source: Bibliographic reference 26. 
Table 3. NUTI diagnosis criteria. 
8. Prevention guidelines 
Even though not all CAUTIs can be prevented, a great number can be avoided by proper 
catheter use. The following care recommendations should be implemented for short-term 
catheterization patients: 
Prevention is directed to three sources: 
1. Catheter colonization precautions. 
2. Once UC is inserted, bacteriuria prevention.  
3. Had bacteriuria developed, its complications should be avoided. 
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8.1 Urinary catheter colonization precautions 
The most successful approach to prevent catheter-associated bacteriuria is to implement 
catheter colonization safety measures. 
1. Use UC only when necessary. 
2. Use external devices: external urinary collectors such as condom catheters for men with 
urinary incontinence is a good alternative, these condoms have devices to connect them 
to a closed drainage system. Even though this system decreases UC use, the urine that 
remains in the condom can induce high bacteria concentration growth in penis skin and 
favor bacteriuria. Further complications can include penis skin maceration, penis ulcers 
and even penis gangrene when condom makes inadequate pressure in penis’ body. 
3. Intermittent catheterization: it is used in patients with sequelae of spinal shock or with 
spinal cord injury. UC insertion for urine voiding and its immediate removal every 4 to 
6 hours only increases bacteriuria in 1 to 3% per catheterization. For intermittent 
catheterization, clean are sterile techniques have been compared. In clean technique, 
catheter can be used again if sterilized at high temperatures before each use, and in 
sterile technique, catheter is new and sterile. There were no differences regarding UTI 
development in any of the two techniques, however, clean technique reduced costs. The 
most common complications are: bleeding, urethritis, fistula, stones,  and hydronephro-
sis. 
4. Suprapubic catheter (cystostomy):  many factors explain the frequency in its use. 
 Abdomen skin has lower bacteria concentration than periurethral area. 
 External obstruction of suprapubic catheters favor urine voiding through the 
urethra. 
 Urethral structures are not injured. 
Besides hematoma in catheter insertion site (abdominal wall), its infection and fistula, 
there are no other important complications. 
5. Gold-coated urethral catheter, polyurethane catheter or antimicrobial catheters have 
been used for long presurgical periods in patients with prostatic hyperplasia diagnosis 
and they have shown interesting results regarding less UTIs, but it cannot be proposed 
as universal recommendation since cost-effectiveness and superinfection evaluation has 
not been fully assessed. (19-22) 
6. Surgical recommendations: Especially in patients with cancer or intractable 
incontinence, bladder reconstruction procedures using colon or ileum segments, like in 
an ileal conduit diversion, bacteriuria is common, producing complications such as: 
acute and chronic pyelonephritis and renal failure secondary to vesicoureteral reflux.  
8.2 Bacteriuria prevention (23-25) 
Once UC is inserted, two strategies are recommended to prevent bacteriuria. 
 Use closed drainage systems: closed drainage systems in permanent catheterized 
patients must always remain closed. Junctures between catheters and collecting bag 
drainage tube must never be opened. Urine samples must be taken through syringe 
puncture and all aseptic measures should be observed during sample collection. 
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8.3 Bacteriuria complications prevention 
Several clinical trials have demonstrated that despite catheterization period, asymptomatic 
bacteriuria need not antibiotic therapy. Nevertheless, some situations need a particular 
evaluation. 
1. In the case that isolated microorganisms might have high bacteremia incidence, e.g. 
Serratia marcescens 
2. Patients with high risk of serious complications: pregnant women, and neutropenic and 
transplanted patients 
3. Patients pending for urologic surgery 
4. Patients with prosthesis.  
In these situations, antibiotic therapy is recommended for asymptomatic bacteriuria since 
complication risks are greatly avoided by this means. 
Antibiotherapy after catheter removal has not proven to be successful either as to prevent 
UTI development or to favor microbiological cure. Likewise, it has been observed that 
catheterized patients with untreated asymptomatic bacteriuria clear it by just catheter 
removal. From prevention guidelines for CAUTIs, the following summary presents the main 
recommendations (16). 
8.4 Main recommendations for catheter-associated urinary tract infection prevention –
Summary— 
Category I. Strongly recommended to adopt 
 Personnel should be given training emphasizing on correct insertion techniques and 
catheter care measures.  
 Urinary catheters should be used only when necessary and left in place only for as long 
as necessary. 
 Promote handwashing and disinfection. 
 Insertion should be done by persons who know the correct aseptic technique using only 
sterile equipment. 
 Catheters should be appropriately assured to avoid urethral traction. 
 Closed drainage system should always remain sterile. 
 Use aseptic techniques for urine sample collection. 
 Urine flow drainage should be kept free.  
Category II. Moderately recommended to adopt 
 Periodic training should be provided to people in charge of catheters. 
 Small catheters should be chosen over catheters with larger diameters. 
 Avoid irrigation unless needed to prevent or control obstruction. 
 Daily meatal care with povidone-iodine should be avoided. 
 Catheters should not be changed at fixed intervals 
Category III. Weakly moderated to adopt 
 Alternative draining techniques should be considered before resorting to 
catheterization. 
 Substitute collecting system when sterile closed drainage has been violated. 
 Separate infected and uninfected catheterized patients. 
 Routine bacteriologic surveillance should be avoided. 
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Urinary infection is the main nosocomial infection and is it associated to urinary catheter 
use. Urinary catheters favor bacteriuria development, which is more frequent when 
catheterization period exceeds 30 days. The most effective solution to decrease bacteriuria 
appearance is to use catheters only when strictly necessary. By reducing catheterization time 
and implementing closed drainage systems, bacteriuria risk can be highly controlled when 
catheterization is needed. Bacteriuria can be asymptomatic, thus not needing antibiotherapy. 
Should bacteriuria complications arise with urinary tract infection symptoms, 
antibiotherapy will highly depend on cystitis and pyelonephritis diagnosis, in either event, 
length of treatment will range between 10 and 21 days. Other strategies aimed to bacteriuria 
prevention have been implemented and they are mainly intended to provide education and 
training to all medical personnel, paramedics and family or people in charge of catheterized 
patient’s care. 
10. Annex – prevention guidelines for catheter-associated urinary tract 
infection- CAUTI (16) 
 Recommendations 
1. PERSONNEL 
 Only persons (hospital team, family or patients) who know the correct insertion 
technique and catheter aseptic maintenance should handle catheters. Category  I 
 Periodic training should be provided to hospital personnel taking care of catheters 
focusing on correct techniques and possible complications during catheterization. 
Category II 
2. CATHETER USE 
 Urinary catheters should only be used when strictly necessary and removed as 
soon as possible. They should not be used for patient-care personnel convinience. 
Category I. 
 For selected patients, alternative urinary draining methods can be used, e.g. 
condom catheter, suprapubic catheter and intermittent catheterization. Category  
III. 
3. HANDWASHING 
 Handwashing is imperative just before and after catheter manipulation. Category I  
4. CATHETER INSERTION 
 Catheters must be inserted using proper aseptic technique and sterile equipment 
Category I. 
 Gloves, gauze, periurethral cleansing antiseptic solution, and single-use packet of 
lubricant should be used for insertion purposes. Category II. 
 Use as small a catheter as possible with good drainage consistency to avoid 
urethral trauma. Category II. 
 Urethral catheters should be properly secured after insertion to prevent movement 
and urethral traction. Category I. 
5. CLOSED STERILE DRAINAGE 
 A closed sterile drainage system should always be mantained. Category I. 
 Catheter and drainage tube should never be disconnected. Category I 
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 If aseptic technique breaks, catheter disconnects from collecting bag or draining 
tube breaks, collecting system should be replaced using aseptic technique after 
disinfecting catheter and tube juncture. Category III. 
6. IRRIGATION 
 Irrigation should be avoided unless obstruction anticipates. Category II 
 Catheter-tube juncture should be disinfected before disconnection. Category II 
 Irrigation solution and siringe must be disposable. Category I 
7. SAMPLE COLLECTION 
 Use sterile syringe Category I 
 Large urine volumes for special analysis can be obtained aseptically from drainage 
bag. Category I 
8. URINARY FLOW 
 Urine flow should be kept free. Category I 
 For unobstructed flow drainage Category I 
a. Disconnection between catheter and draining tube should be avoided. 
b. Draining bag should be cleared regularly using a separate collecting container for 
each patient.  
c. Poorly functioning or obstructed catheters need to be irrigated or replaced if 
necessary.  
d. Draining bag must be kept below patient’s bladder.  
9. MEATAL CARE WITH SOAP AND WATER OR WITH POVIDONE-IODINE  
 Daily cleansing with antiseptic solutions or soap and water do not reduce NUTI 
probability. Category II  
10. CATHETER CHANGE INTERVAL 
 Catheters should not be changed at fixed intervals. Category II 
11. SPATIAL SEPARATION OF CATHETERIZED PATIENTS  
 To diminish cross infection among uninfected and infected patients, they should be 
separarated Category III 
12. BACTERIOLOGIC SURVEILLANCE 
 Routine bacteriologic surveillance is not recommended for catheterized patients. 
Category III 
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